L-R4W2Cat. No. 1577 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
Biological Activity
Vanilloid TRPV1 (VR1) receptor antagonist peptide (IC50 ~ 0.1 μM); blocks Ca2+ currents in dorsal root ganglion neurons. Analgesic in vivo.Technical Data
M.Wt:(Modifications: Trp-6 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
References
Planells-Cases et al (2000) Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett. 481 131. PMID: 10996311.
Himmel et al (2002) The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J.Pharmacol.Exp.Ther. 301 981. PMID: 12023528.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: L-R4W2, supplier, TRPV1, antagonists, peptide, Vanillioid, Receptors, VR1, TRPV, Channels, Transient, Receptor, Potential
Quick Order
Find multiple products by catalog number
New Products in this Area
Inhibits TRPP3-mediated currents; also inhibits the Na+/H+ exchanger (NHE)
ML SA1Activator of TRPML channels
PhenamilInhibits TRPP3-mediated currents; also inhibits epithelial Na+ channels
α-SpinasterolTRPV1 antagonist; displays in vivo activity
ML 204Selective TRPC4 blocker
A 967079Selective TRPA1 channel blocker
Tocris Events
Win a Kindle
11th Annual Meeting of the International Society for Stem Cell Research
June 12 - 15, 2013
Boston, MA
Booth Number: 213



